BrainImage offers the SonoClear System, a sterile acoustic coupling fluid designed to enhance ultrasound imaging by mimicking the ultrasound signatures of healthy tissue. This technology improves tumor border visualization during neurosurgical procedures, reducing the risk of neurological deficits and increasing diagnostic accuracy.
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
During neurosurgical procedures, accurately visualizing tumor borders with ultrasound is challenging due to the similarity in acoustic signatures between healthy tissue and tumors. This can lead to incomplete tumor resection, increasing the risk of neurological deficits and reducing diagnostic accuracy.
Solution
SonoClear has developed the SonoClear System, a sterile acoustic coupling fluid designed to enhance ultrasound imaging during neurosurgery. The fluid is engineered to mimic the ultrasound signatures of healthy tissue, creating a clearer contrast between the tumor and surrounding tissue. This improved visualization enables neurosurgeons to more precisely delineate tumor borders, potentially leading to more complete resections and reduced risk of neurological damage. The SonoClear System aims to provide neurosurgeons with the clarity needed to make critical decisions during tumor removal.
Target Audience
The primary users are neurosurgeons performing ultrasound-guided tumor resections.
Features
- Sterile, advanced acoustic couplant
- Engineered to mimic the ultrasound signatures of normal healthy tissue
- Designed to improve diagnostic accuracy of ultrasound images during intraoperative procedures
- Enhances tumor border visualization